Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.07 [0.03-0.14],2.11177380932076e-12,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.14 [0.04-0.45],0.00109132804703645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.79 [1.21-2.63],0.00347775771110042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.01 [0-0.3],0.010061832950356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.71 [1.12-2.61],0.0133406951314638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.85 [1.11-3.06],0.0172943919656406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.5 [0.27-0.91],0.0235098540106377,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.45 [0.21-0.94],0.0327518326660789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.7 [0.5-0.97],0.0348016325058723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.6 [0.36-0.99],0.0437907678208902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.24 [1-1.55],0.053786740043642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,2.5 [0.98-6.36],0.0554547296572217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.61 [0.37-1.01],0.0567937626970816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.24 [0.99-1.55],0.0577881662348247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.34 [0.11-1.06],0.0629268284836114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.16 [0.99-1.36],0.0635020739900376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,4.46 [0.86-23.17],0.0750214944867784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,22.73 [0.65-796.71],0.0851942630983787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,2.94 [0.82-10.56],0.0989686972569175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,2.71 [0.82-8.97],0.102126237443568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.69 [0.44-1.08],0.108336474788931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.7 [0.89-3.27],0.108545050263291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SEPTIN8,Septin-8,Inverse variance weighted,2,2.15 [0.83-5.57],0.115015058045349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.56 [0.27-1.16],0.119639779487178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.46 [0.17-1.23],0.120566025001407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PVR,Poliovirus receptor,Inverse variance weighted,27,1.15 [0.96-1.39],0.132360502137339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.78 [0.84-3.79],0.134619837026157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.84 [0.66-1.06],0.136385382562169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NECTIN4,Nectin-4,Inverse variance weighted,7,0.74 [0.49-1.1],0.136505441742977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.65 [0.85-3.21],0.140730899614761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.79 [0.58-1.08],0.141835808235808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,COLEC12,Collectin-12,Inverse variance weighted,11,0.68 [0.41-1.14],0.144238025605011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SCG2,Secretogranin-2,Wald ratio,1,0.12 [0.01-2.1],0.146339335375415,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.63 [0.34-1.18],0.147496587192623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.89 [0.79-4.55],0.153214846118621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.92 [0.78-4.71],0.155723881056533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPON2,Spondin-2,Inverse variance weighted,4,1.52 [0.85-2.71],0.156702564064566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.58 [0.84-2.98],0.15896213817586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.34 [0.08-1.54],0.162380049818663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.38 [0.87-2.19],0.166345725364396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.22 [0.02-2.03],0.179483125402258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.56 [0.24-1.31],0.181858261644409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.28 [0.89-1.85],0.183522501438101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,UMOD,Uromodulin,Inverse variance weighted,29,0.89 [0.75-1.06],0.189283863600632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.43 [0.84-2.44],0.192340479795804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.24 [0.89-1.72],0.196128223785008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.15 [0.93-1.42],0.200427681923678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.91 [0.79-1.05],0.210466174999656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.65 [0.75-3.6],0.211881475455916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.25 [0.88-1.8],0.217525631043301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.77 [0.51-1.17],0.222415862515558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.79 [0.53-1.17],0.230253553237383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.21 [0.02-2.69],0.231135189685397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.87 [0.69-1.1],0.23884512155395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.74 [0.68-4.42],0.245943567034951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.68 [0.36-1.3],0.246408172221462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.16 [0.9-1.49],0.247234868759053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.5 [0.75-2.98],0.249348018741556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.66 [0.68-4.03],0.261526191124754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.59 [0.71-3.58],0.262823688274675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.61 [0.25-1.48],0.272498870656633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.16 [0.89-1.53],0.274556416399751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPON1,Spondin-1,Inverse variance weighted,21,0.83 [0.59-1.16],0.274874659011272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CHGA,Chromogranin-A,Inverse variance weighted,3,1.81 [0.62-5.23],0.275685313291746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.11 [0.92-1.33],0.283198699579591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,C7,Complement component C7,Inverse variance weighted,38,0.92 [0.78-1.08],0.292028645505543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.77 [0.47-1.26],0.301950337733829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NECTIN2,Nectin-2,Inverse variance weighted,5,0.78 [0.49-1.25],0.302260666651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.14 [0.88-1.48],0.314948678700327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.81 [0.53-1.23],0.315824951461874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CST3,Cystatin-C,Inverse variance weighted,10,0.81 [0.54-1.23],0.319813876987497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PGF,Placenta growth factor,Inverse variance weighted,2,0.16 [0-6.14],0.327472432523759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.87 [0.65-1.16],0.342478020564962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD160,CD160 antigen,Inverse variance weighted,11,1.17 [0.84-1.63],0.354506624264908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.51 [0.13-2.1],0.354536567402866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DSC2,Desmocollin-2,Inverse variance weighted,9,0.81 [0.51-1.27],0.358485094419943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.89 [0.69-1.15],0.369879499753752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.53 [0.13-2.13],0.370347602266062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,0.76 [0.42-1.38],0.371133990163794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CALCA,Calcitonin,Inverse variance weighted,5,0.62 [0.22-1.78],0.374636125710938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.28 [0.74-2.2],0.376775239701067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PSAP,Prosaposin,Inverse variance weighted,5,0.66 [0.27-1.65],0.376894287719183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PRSS8,Prostasin,Inverse variance weighted,5,1.53 [0.59-3.99],0.383941345889433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.94 [0.81-1.09],0.384962222016985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.52 [0.59-3.96],0.387428209943104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.92 [0.76-1.12],0.392043293543903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.88 [0.64-1.2],0.413681925992758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.32 [0.67-2.57],0.419226780614942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,2.44 [0.28-21.46],0.421827088940307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LGALS9,Galectin-9,Inverse variance weighted,26,0.88 [0.63-1.21],0.423345133593568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.09 [0.88-1.34],0.429295435741285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CTSL,Cathepsin L1,Wald ratio,1,0.31 [0.02-6.07],0.442809597815486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.73 [0.33-1.63],0.444533132729548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.35 [0.02-5.52],0.457323447718657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.07 [0.9-1.27],0.458244093926805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PALM2,Paralemmin-2,Inverse variance weighted,8,1.27 [0.68-2.37],0.458424495788493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KLK11,Kallikrein-11,Inverse variance weighted,6,1.11 [0.84-1.47],0.461338377853591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REN,Renin,Inverse variance weighted,4,1.19 [0.75-1.91],0.461687838146675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.24 [0.7-2.19],0.465584454460354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LAYN,Layilin,Inverse variance weighted,20,1.16 [0.77-1.75],0.46605537720884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HSPB6,Heat shock protein beta-6,Wald ratio,1,3.43 [0.12-101.42],0.475976954732181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.63 [0.17-2.27],0.477643584934043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.37 [0.57-3.3],0.483194897315238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.13 [0.79-1.62],0.492323733858571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GRN,Progranulin,Inverse variance weighted,7,1.16 [0.75-1.78],0.498449436094475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.87 [0.57-1.33],0.508158564051918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.51 [0.07-3.84],0.511988947911866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.11 [0.81-1.53],0.519314084617841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.57 [0.09-3.44],0.538491838189673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.45 [0.44-4.77],0.539375613690405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL19,Interleukin-19,Inverse variance weighted,11,1.13 [0.76-1.69],0.551748901562753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.32 [0.52-3.34],0.560591790731703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.76 [0.3-1.94],0.572266744167161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD48,CD48 antigen,Inverse variance weighted,18,1.07 [0.85-1.33],0.573820659119151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.89 [0.6-1.33],0.575331849233248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.12 [0.76-1.64],0.580968160487357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.8 [0.37-1.76],0.586000311797335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.04 [0.89-1.23],0.601650800050421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.43 [0.02-10.25],0.601912302195199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.16 [0.65-2.09],0.609158519197799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.1 [0.75-1.62],0.609906593798618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.07 [0.83-1.37],0.610788797648677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.03 [0.91-1.18],0.61184072649417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.44 [0.02-10.86],0.616425084870373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.07 [0.83-1.37],0.621830648411118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.09 [0.77-1.55],0.624758196598044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.74 [0.22-2.49],0.625000729740844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.93 [0.67-1.28],0.654972885460969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.06 [0.83-1.35],0.657098125153344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.06 [0.81-1.4],0.6621531352866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NFASC,Neurofascin,Inverse variance weighted,15,1.08 [0.77-1.5],0.662960198722698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.53 [0.03-9.65],0.664878883021963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD302,CD302 antigen,Inverse variance weighted,9,0.91 [0.57-1.44],0.677270249359744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.77 [0.23-2.61],0.678236785106192,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.38 [0.3-6.31],0.680564876401035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,MMP7,Matrilysin,Inverse variance weighted,13,1.08 [0.75-1.56],0.681233242593517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.09 [0.72-1.65],0.689485121499409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.13 [0.61-2.11],0.690065060356712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.05 [0.81-1.36],0.697334926550249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,OCLN,Occludin,Inverse variance weighted,2,0.81 [0.29-2.32],0.700319560529117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL15,Interleukin-15,Wald ratio,1,0.08 [0-137946.44],0.725493209398339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.22 [0.39-3.84],0.72934177199878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.42 [0-60.36],0.729654582555405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.87 [0.39-1.95],0.732088813413515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPP1,Osteopontin,Inverse variance weighted,8,1.18 [0.46-2.99],0.733151692035277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.82 [0.25-2.64],0.734439068716732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.94 [0.66-1.35],0.741161781969909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.09 [0.65-1.85],0.742105254092375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.06 [0.72-1.58],0.757706371184424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,AGRN,Agrin,Inverse variance weighted,17,0.93 [0.59-1.47],0.763601115175068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.93 [0.6-1.46],0.767849963636158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.71 [0.07-7.17],0.769706115177608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.07 [0.68-1.69],0.773031859324803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.05 [0.74-1.5],0.774623476823879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD276,CD276 antigen,Inverse variance weighted,20,1.03 [0.81-1.32],0.788636780471993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.88 [0.33-2.35],0.795566132174517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.07 [0.64-1.8],0.797724799193862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LGALS4,Galectin-4,Inverse variance weighted,4,1.11 [0.48-2.59],0.800232331407689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.04 [0.76-1.42],0.802572055463101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.19 [0.3-4.73],0.807592875159173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.97 [0.72-1.31],0.832815935058196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.96 [0.67-1.39],0.832836303669692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.97 [0.69-1.36],0.84072532601328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,OGN,Mimecan,Inverse variance weighted,30,0.97 [0.74-1.28],0.842450412188591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.89 [0.25-3.11],0.850257400501556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.96 [0.6-1.53],0.853780540339405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.11 [0.38-3.21],0.853973996278686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.93 [0.39-2.19],0.865816142137604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.06 [0.53-2.12],0.867332924025678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.85-1.21],0.868339334858071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LMNB2,Lamin-B2,Wald ratio,1,1.23 [0.05-33.5],0.902751490682925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,AREG,Amphiregulin,Inverse variance weighted,3,0.93 [0.3-2.87],0.90376226228585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.02 [0.73-1.42],0.905211776290413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.97 [0.59-1.6],0.907657663165943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.97 [0.62-1.53],0.910197727848941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.82-1.25],0.919145904534675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.07 [0.25-4.53],0.922828101131182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.93 [0.16-5.38],0.936415535725158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.04 [0.41-2.65],0.937601300888331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.01 [0.75-1.37],0.943189704584804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.99 [0.67-1.46],0.949394871409903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD27,CD27 antigen,Inverse variance weighted,9,1.01 [0.68-1.5],0.950521304056599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,BSG,Basigin,Wald ratio,1,1.03 [0.38-2.77],0.954398152816171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.94 [0.11-8.28],0.958586873970875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.99 [0.76-1.29],0.962958834770348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1 [0.77-1.29],0.970030700990579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.03 [0.18-5.76],0.976261034236202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.99 [0.6-1.65],0.977268017906534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.02 [0.2-5.31],0.980129475180672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD83,CD83 antigen,Inverse variance weighted,5,1 [0.5-1.98],0.995450471284241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1 [0.78-1.27],0.996337889860039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.44 [0.26-0.74],0.00196481163553514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GRN,Progranulin,Inverse variance weighted,46,1.43 [1.14-1.81],0.00233379489406483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.4 [0.21-0.77],0.0059452706231875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,3.27 [1.35-7.9],0.00844176885561627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,2.81 [1.29-6.12],0.00924993895910722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.54 [0.34-0.87],0.0102847042801233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,7.34 [1.43-37.63],0.0168915149580812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.11 [0.02-0.69],0.0184020847560212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.24 [0.07-0.79],0.019481330523515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KLK11,Kallikrein-11,Inverse variance weighted,13,0.46 [0.23-0.91],0.0263997724680069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SHISA5,Protein shisa-5,Inverse variance weighted,12,3.1 [1.12-8.54],0.0290823270629195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.19 [1.02-1.4],0.0313361418511497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.29 [0.09-0.92],0.0346551133961814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.05 [0-0.95],0.0460505234517282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,BSG,Basigin,Inverse variance weighted,6,0.3 [0.09-0.98],0.0468362422084043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.48 [0.23-1.02],0.056614308251563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,2.19 [0.97-4.98],0.0600198175485703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.37 [0.12-1.12],0.0796996155957247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SCG2,Secretogranin-2,Inverse variance weighted,2,0.23 [0.04-1.3],0.0962834192604902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PSAP,Prosaposin,Inverse variance weighted,13,0.63 [0.36-1.09],0.100293386979522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LGALS4,Galectin-4,Inverse variance weighted,15,0.73 [0.5-1.06],0.102683586296203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.79 [0.58-1.06],0.112761964158058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.76 [0.87-3.58],0.114821747096395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,2.1 [0.83-5.31],0.1183371984763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD160,CD160 antigen,Inverse variance weighted,24,1.53 [0.89-2.61],0.123135876458028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,OCLN,Occludin,Inverse variance weighted,2,5.49 [0.63-47.99],0.123628516536637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,2.66 [0.74-9.51],0.132347641364732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PRSS8,Prostasin,Inverse variance weighted,14,1.78 [0.82-3.84],0.143147041590873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.53 [0.23-1.25],0.146463620015621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,2.43 [0.73-8.06],0.146702392423444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.51 [0.2-1.29],0.154823887178758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.84 [0.79-4.28],0.155928965299311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GDF15,Growth/differentiation factor 15,Wald ratio,1,18.08 [0.33-989.06],0.156270470423948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.75 [0.5-1.12],0.160028626395687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.52 [0.2-1.32],0.169102475134749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,4.47 [0.53-38],0.170372028154497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.22 [0.02-2.03],0.179483125402258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CST3,Cystatin-C,Inverse variance weighted,3,0.29 [0.05-1.84],0.190036708690781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,3.15 [0.57-17.5],0.19069082220011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.54 [0.21-1.36],0.192509373998157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.38 [0.09-1.63],0.193517875262908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.46 [0.15-1.48],0.193596415695808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD83,CD83 antigen,Inverse variance weighted,14,0.56 [0.24-1.34],0.194743021925002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SEPTIN8,Septin-8,Inverse variance weighted,4,0.45 [0.13-1.55],0.205856605550512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.5 [0.17-1.48],0.208947352188185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,2.43 [0.6-9.87],0.212702509717264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.5 [0.78-2.89],0.221347984735849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.72 [0.42-1.22],0.22422639221829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.89 [0.67-5.31],0.227535991377513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.48 [0.14-1.62],0.238270654167076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.76 [0.68-4.56],0.243907108662736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.62 [0.28-1.39],0.244725010435625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.9 [0.64-5.59],0.245632691663625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.54 [0.19-1.53],0.246888393719247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,2.13 [0.59-7.7],0.248082002454558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.56 [0.21-1.5],0.250759795851586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.46 [0.12-1.74],0.254632444719226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.47 [0.13-1.74],0.258892027161441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.42 [0.75-2.69],0.275822579902652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,UMOD,Uromodulin,Inverse variance weighted,34,1.35 [0.76-2.38],0.300819520410714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.17 [0.87-1.59],0.303144186026832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CHGA,Chromogranin-A,Inverse variance weighted,5,1.69 [0.61-4.66],0.312279312504202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPON2,Spondin-2,Inverse variance weighted,3,0.39 [0.06-2.45],0.313839224103332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NFASC,Neurofascin,Inverse variance weighted,6,2.03 [0.51-8.11],0.315859350612366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.33 [0.76-2.31],0.317876714437304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPP1,Osteopontin,Inverse variance weighted,13,0.59 [0.2-1.69],0.321931853912819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.68 [0.31-1.48],0.332678028843472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.97 [0.49-7.85],0.337224555404954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.6 [0.21-1.71],0.340299124710626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.71 [0.57-5.17],0.341006069897144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.49 [0.65-3.37],0.34334285075804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,4.35 [0.21-91.97],0.344470797416778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD276,CD276 antigen,Inverse variance weighted,24,1.24 [0.79-1.93],0.354704896478044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.18 [0.83-1.68],0.361419172953682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.31 [0.74-2.32],0.362469406964352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.9 [0.72-1.13],0.368577510185004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.89 [0.46-7.68],0.375508669454841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.56 [0.15-2.12],0.390582654122288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GAST,Gastrin,Inverse variance weighted,9,0.72 [0.34-1.53],0.395731342791718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.99 [0.4-9.97],0.404011923988181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.24 [0.01-7.17],0.406823519235109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.35 [0.03-4.27],0.410401253700273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.33 [0.67-2.62],0.412260274758207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.99 [0.38-10.46],0.418631060821154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CALCA,Calcitonin,Inverse variance weighted,13,1.46 [0.58-3.65],0.419360772785945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.71 [0.31-1.64],0.419735750810352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD27,CD27 antigen,Inverse variance weighted,9,1.51 [0.55-4.13],0.422776014629683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD302,CD302 antigen,Inverse variance weighted,11,0.77 [0.4-1.47],0.426855598760144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.41 [0.04-3.77],0.429202252090711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.82 [0.49-1.37],0.438818579907694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.47 [0.54-3.99],0.445835183440168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PGF,Placenta growth factor,Inverse variance weighted,5,0.66 [0.22-1.95],0.448604438417515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,AGRN,Agrin,Inverse variance weighted,14,0.73 [0.33-1.65],0.453899340781527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL15,Interleukin-15,Inverse variance weighted,35,0.86 [0.58-1.27],0.45455436316184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CTSL,Cathepsin L1,Inverse variance weighted,29,1.19 [0.76-1.86],0.455102899864884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,MMP7,Matrilysin,Wald ratio,1,1.59 [0.46-5.55],0.463605153505806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.73 [0.31-1.71],0.470693005372758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.67 [0.23-1.98],0.473984384568472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,COLEC12,Collectin-12,Inverse variance weighted,3,1.97 [0.29-13.28],0.48452962354766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PALM2,Paralemmin-2,Inverse variance weighted,9,1.23 [0.68-2.22],0.48822550713435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.32 [0.01-8.12],0.488911572742713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.52 [0.08-3.28],0.489324602699426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.84 [0.5-1.4],0.495195042861496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DSC2,Desmocollin-2,Inverse variance weighted,16,0.87 [0.58-1.3],0.502253709720685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.76 [0.34-1.72],0.513830782127033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.57 [0.1-3.16],0.519011114112633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.8 [0.41-1.57],0.522428995901685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,OGN,Mimecan,Inverse variance weighted,37,1.1 [0.82-1.46],0.526887392850577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.7 [0.33-8.78],0.528890051931857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.91 [0.24-15.18],0.540860052689375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.64 [0.32-8.3],0.55169333890574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.77 [0.32-1.83],0.553668945482857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.09 [0.8-1.5],0.569992254918359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.65 [0.13-3.24],0.596037735663852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.51 [0.33-6.9],0.596415558155268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.41 [0.01-11.76],0.605218030243707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.88 [0.54-1.43],0.610331955476964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.14 [0.69-1.89],0.612695172926845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LAYN,Layilin,Inverse variance weighted,3,2.02 [0.13-31.81],0.615824478128945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.91 [0.63-1.32],0.61761592072587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NECTIN2,Nectin-2,Inverse variance weighted,3,0.52 [0.04-6.67],0.618362775966262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.12 [0.72-1.75],0.619857828292363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.24 [0.5-3.03],0.642807061955481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.2 [0.53-2.72],0.656153226149953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,0.73 [0.18-2.98],0.662476787134846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.71 [0.14-20.67],0.671262167021455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.1 [0.72-1.67],0.67277670432584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.33 [0.35-5.11],0.6785751538784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.21 [0.47-3.14],0.690453854375752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.83 [0.34-2.06],0.69469455950663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.95 [0.72-1.25],0.702634528552799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.05 [0.81-1.35],0.70668031208704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.17 [0.52-2.64],0.707325614958613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.36 [0.27-6.72],0.709747125825064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.05 [0.81-1.37],0.716188704428636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.1 [0.66-1.83],0.720544438034515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.43 [0.2-10.47],0.723911791481369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.34 [0.25-7.22],0.73011836149453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.58 [0.03-13.31],0.732406660965734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LMNB2,Lamin-B2,Inverse variance weighted,8,1.27 [0.32-4.96],0.733704758523752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.82 [0.25-2.64],0.734036592696222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.92 [0.57-1.5],0.738895898167835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.91 [0.5-1.65],0.758711288379958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.04 [0.82-1.3],0.76074212017552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.82 [0.21-3.17],0.768093881849892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL19,Interleukin-19,Inverse variance weighted,10,0.92 [0.54-1.59],0.769619628254665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,NECTIN4,Nectin-4,Inverse variance weighted,4,1.26 [0.26-6.06],0.770191439249366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.14 [0.46-2.87],0.77521589509582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.13 [0.47-2.71],0.786680706641753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.25 [0.24-6.68],0.790237264606643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.9 [0.42-1.93],0.791444761367152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.81 [0.15-4.23],0.7993839055431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.27 [0.19-8.69],0.806936992991608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.85 [0.24-3.07],0.809657101803169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.13 [0.41-3.09],0.810060724498158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.13 [0.42-3],0.810181788068732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.47 [0.06-35.91],0.812453342614435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.67 [0.03-17.69],0.812462284580276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.06 [0.65-1.72],0.81286134070964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.77 [0.09-6.88],0.815759517399735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.13 [0.37-3.52],0.827139096101139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.1 [0.47-2.56],0.834170581093715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.78 [0.08-8.08],0.834661557553654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.08 [0.53-2.17],0.835633756764457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.14 [0.3-4.37],0.845365458785065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.95 [0.53-1.68],0.852189207668094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REN,Renin,Inverse variance weighted,8,1.13 [0.3-4.24],0.854661218086277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.06 [0.55-2.07],0.857140987730558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.13 [0.29-4.37],0.857878572659989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.97 [0.72-1.31],0.859090093176129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.74 [0.02-21.86],0.860468908652688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,C7,Complement component C7,Inverse variance weighted,26,1.02 [0.78-1.34],0.861337475610351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.88 [0.21-3.78],0.863740632419413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,PVR,Poliovirus receptor,Inverse variance weighted,3,1.18 [0.18-7.95],0.864204370110777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.05 [0.61-1.81],0.865654195487717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.1 [0.36-3.35],0.870040703026609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.88 [0.19-4.05],0.871442846167553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.92 [0.35-2.44],0.872594916896081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.05 [0.55-2.01],0.886232145329897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD48,CD48 antigen,Inverse variance weighted,14,0.95 [0.44-2.04],0.894811256036187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.05 [0.5-2.2],0.895390479135774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.84 [0.05-13.88],0.900282378892439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.05 [0.48-2.29],0.905362919353053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.89 [0.12-6.44],0.907751700745226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.82-1.25],0.920749208082878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.61-1.57],0.931127545812704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.95 [0.24-3.76],0.938231036532403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,SPON1,Spondin-1,Inverse variance weighted,4,0.95 [0.24-3.8],0.940965470968219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.94 [0.15-6.03],0.947171441481764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,AREG,Amphiregulin,Inverse variance weighted,5,0.96 [0.28-3.27],0.948625379073819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.05 [0.18-6.22],0.953723649940503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.03 [0.35-3.04],0.956288189690659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,LGALS9,Galectin-9,Inverse variance weighted,36,1.01 [0.76-1.34],0.960936568907218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.01 [0.53-1.93],0.980610211557975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.98 [0.27-3.56],0.980857188210415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1 [0.64-1.57],0.98475483173939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.01 [0.23-4.37],0.985988597415354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.99 [0.26-3.71],0.986743593514439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1 [0.67-1.5],0.988023830989487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1 [0.48-2.09],0.989541084276588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1 [0.5-1.99],0.999743239842136,trans
